Optiprost Eye Drop: Bimatoprost 0.03% - Essential Glaucoma Therapy

Mechanism of Action: Prostaglandin Analog for Enhanced Aqueous Outflow

Key Indications: Reducing Elevated Intraocular Pressure (IOP) and Ocular Hypertension

Dosage Advantage: Convenient Once-Daily Application for Chronic Management

Important: Monitoring IOP and Managing Potential Side Effects
Exclusive Territory: Optiprost Eye Drop PCD Pharma Franchise in Chronic Care

Optiprost Eye Drop

Composition : Bimatoprost 0.03%w/v Benzalkonium Chloride Solution I.P. 0.01%v/v

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹0/-

Please Contact For Best Price

Optiprost Eye Drop is a critical medication in the management of chronic eye conditions, specifically containing Bimatoprost 0.03% w/v. This strength is widely recognized as a highly effective treatment for lowering elevated intraocular pressure (IOP) in patients diagnosed with open-angle glaucoma or ocular hypertension.

Mechanism and Impact:Bimatoprost is a prostaglandin analog that works primarily by significantly increasing the outflow of aqueous humor (the fluid inside the eye) through the uveoscleral pathway. This enhanced drainage mechanism directly reduces the pressure inside the eye, which is vital for preventing progressive damage to the optic nerve and subsequent vision loss associated with glaucoma. The formulation includes Benzalkonium Chloride as a preservative.

Key Therapeutic Uses:

  • Glaucoma Treatment: Used alone or in combination with other drops to maintain target IOP levels.

  • Ocular Hypertension: Prevents the progression of high eye pressure to full glaucoma.

We offer an exclusive PCD Pharma Franchise opportunity for Optiprost Eye Drop, securing your access to a high-value, long-term market segment focused on chronic eye disease management.

Read More

About the Product

Optiprost Eye Drop is a critical medication in the management of chronic eye conditions, specifically containing Bimatoprost 0.03% w/v. This strength is widely recognized as a highly effective treatment for lowering elevated intraocular pressure (IOP) in patients diagnosed with open-angle glaucoma or ocular hypertension.

Mechanism and Impact:Bimatoprost is a prostaglandin analog that works primarily by significantly increasing the outflow of aqueous humor (the fluid inside the eye) through the uveoscleral pathway. This enhanced drainage mechanism directly reduces the pressure inside the eye, which is vital for preventing progressive damage to the optic nerve and subsequent vision loss associated with glaucoma. The formulation includes Benzalkonium Chloride as a preservative.

Key Therapeutic Uses:

  • Glaucoma Treatment: Used alone or in combination with other drops to maintain target IOP levels.

  • Ocular Hypertension: Prevents the progression of high eye pressure to full glaucoma.

We offer an exclusive PCD Pharma Franchise opportunity for Optiprost Eye Drop, securing your access to a high-value, long-term market segment focused on chronic eye disease management.

Common, mild side effects may include brief eye irritation, slight discomfort, or a temporary burning sensation upon application.

Moxolunic BF Eye Drop (BAK Free) Indicated for treating bacterial eye infections, reducing post-surgical pain, redness, and swelling, and alleviating associated itching and discomfort.

Information regarding the use of Moxolunic BF Eye Drop (BAK Free) during breastfeeding is not available. Please consult your doctor.

Store in a cool, dry place at room temperature (15°C to 25°C). Keep the bottle tightly closed and away from direct sunlight. Keep out of reach of children.

Get in Touch